BQD(03866): Liu Xiaoshu was elected as an employee director.
Qingdao Bank (03866) announced that Qingdao Bank Co., Ltd. (referred to as the Bank or Qingdao Bank) held the sixth fourth employee representative assembly on June 16, 2026, and elected Mr. Liu Xiaoshu as the employee director of the ninth board of directors of the Bank. His qualification for appointment still needs to be approved by the Qingdao Regulatory Bureau of the China Banking and Insurance Regulatory Commission. His term of office will be from the date when the regulatory agency approves his qualification until the expiration of the term of office of the ninth board of directors of the Bank.
BQD (03866) announces that BQD Co., Ltd. convened the sixth session of the fourth employee representative congress on June 16, 2026, and elected Mr. Liu Xiaoshu as the employee director of the ninth board of directors of the company. His qualification for this position still needs to be approved by the Qingdao Regulatory Bureau of the China Banking and Insurance Regulatory Commission. His term of office will be from the date of approval by the regulatory agency until the expiration of the ninth board of directors of the company.
Related Articles
On June 16, HANXBIO-B (03378) spent 320,500 Hong Kong dollars to repurchase 11,900 shares.
CSPC PHARMA (01093): The application for the listing permit of Valsartan and Amlodipine Maleate Tablets (SYH 9056 Tablets) has been accepted by the National Medical Products Administration.
REGENT PACIFIC(00575): Senstend receives a milestone approval from the National Medical Products Administration.
On June 16, HANXBIO-B (03378) spent 320,500 Hong Kong dollars to repurchase 11,900 shares.
CSPC PHARMA (01093): The application for the listing permit of Valsartan and Amlodipine Maleate Tablets (SYH 9056 Tablets) has been accepted by the National Medical Products Administration.
REGENT PACIFIC(00575): Senstend receives a milestone approval from the National Medical Products Administration.
RECOMMEND
